Title | Type | SJR | H index | Total Docs. (2004) | Total Docs. (3years) | Total Refs. (2004) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2004) | %Female (2004) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
141 | Advances in Antiviral Drug Design | book series | 0.106 Q4 | 12 | 0 | 7 | 0 | 1 | 7 | 0.14 | 0.00 | 0.00 | |
140 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.314 Q3 | 25 | 0 | 40 | 0 | 57 | 30 | 1.89 | 0.00 | 0.00 | |
139 | American Journal of PharmacoGenomics | journal | 1.175 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
138 | American Journal of Respiratory Medicine | journal | 0.343 Q3 | 34 | 0 | 93 | 0 | 120 | 87 | 1.29 | 0.00 | 0.00 | |
137 | Chemical Speciation and Bioavailability | journal | 0.395 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
136 | Comments on Toxicology | journal | 0.214 Q4 | 13 | 0 | 59 | 0 | 20 | 51 | 0.23 | 0.00 | 0.00 | |
135 | Current Drug Discovery | journal | 0.190 Q3 | 13 | 97 | 304 | 0 | 58 | 181 | 0.19 | 0.00 | 22.99 | |
134 | Cytokines, Cellular and Molecular Therapy | journal | 0.283 Q3 | 28 | 0 | 21 | 0 | 24 | 21 | 1.14 | 0.00 | 0.00 | |
133 | Drug Design and Discovery | journal | 0.296 Q3 | 20 | 0 | 17 | 0 | 12 | 16 | 0.75 | 0.00 | 0.00 | |
132 | International Antiviral News | journal | 0.101 Q4 | 8 | 0 | 25 | 0 | 0 | 23 | 0.00 | 0.00 | 0.00 | |
131 | Manufacturing Chemist | trade journal | 0.101 Q4 | 6 | 0 | 906 | 0 | 0 | 18 | 0.00 | 0.00 | 0.00 | |
130 | Pharmaceutical News | journal | 0.127 Q3 | 11 | 0 | 138 | 0 | 32 | 120 | 0.33 | 0.00 | 0.00 | |
129 | Pharmaceutical Visions | journal | 0.101 Q4 | 2 | 0 | 28 | 0 | 2 | 27 | 0.00 | 0.00 | 0.00 | |
128 | Pharmacology Reviews and Communications | journal | 0.168 Q3 | 9 | 0 | 49 | 0 | 17 | 49 | 0.52 | 0.00 | 0.00 | |
127 | Progress in Pharmaceutical and Biomedical Analysis | book series | 0.101 Q4 | 8 | 0 | 17 | 0 | 0 | 16 | 0.00 | 0.00 | 0.00 | |
126 | Toxicology Methods | journal | 0.234 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
125 | Journal of Clinical Research | journal | 0.122 Q4 | 12 | 1 | 14 | 23 | 8 | 14 | 0.50 | 23.00 | 16.67 | |
124 | European Journal of Herbal Medicine | journal | 0.102 Q4 | 3 | 5 | 23 | 46 | 1 | 14 | 0.00 | 9.20 | 50.00 | |
123 | BMC Chemical Biology | journal | 0.197 Q4 | 21 | 2 | 6 | 77 | 2 | 6 | 0.00 | 38.50 | 20.00 | |
122 | Particle and Fibre Toxicology | journal | 119 | 3 | 0 | 78 | 0 | 0 | 0.00 | 26.00 | 16.67 | ||
121 | Drug Discovery World | journal | 14 | 10 | 0 | 146 | 0 | 0 | 0.00 | 14.60 | 0.00 | ||
120 | Quality Assurance Journal | journal | 0.124 Q4 | 11 | 35 | 82 | 165 | 9 | 69 | 0.11 | 4.71 | 31.67 | |
119 | Journal of Negative Results in BioMedicine | journal | 0.126 Q3 | 25 | 7 | 7 | 195 | 4 | 5 | 0.57 | 27.86 | 21.43 | |
118 | BMC Clinical Pharmacology | journal | 0.897 Q2 | 43 | 6 | 16 | 212 | 33 | 16 | 1.33 | 35.33 | 39.29 | |
117 | EPC - European Pharmaceutical Contractor | journal | 0.100 Q4 | 3 | 102 | 199 | 226 | 4 | 143 | 0.02 | 2.22 | 25.44 | |
116 | British Journal of Clinical Pharmacology, Supplement | journal | 0.705 Q1 | 33 | 7 | 38 | 244 | 131 | 35 | 3.65 | 34.86 | 16.67 | |
115 | Journal of Nanobiotechnology | journal | 0.449 Q2 | 109 | 12 | 6 | 343 | 12 | 6 | 2.00 | 28.58 | 7.14 | |
114 | Pharmacy in Practice | journal | 0.112 Q4 | 6 | 62 | 97 | 352 | 4 | 79 | 0.06 | 5.68 | 56.90 | |
113 | Paediatric and Perinatal Drug Therapy | journal | 0.139 Q4 | 20 | 13 | 47 | 354 | 16 | 40 | 0.41 | 27.23 | 47.50 | |
112 | Journal of Immune Based Therapies and Vaccines | journal | 0.264 Q3 | 21 | 9 | 5 | 367 | 6 | 4 | 1.20 | 40.78 | 46.81 | |
111 | Journal of Applied Therapeutic Research | journal | 0.129 Q4 | 8 | 19 | 18 | 388 | 4 | 18 | 0.22 | 20.42 | 37.29 | |
110 | Autonomic and Autacoid Pharmacology | journal | 0.318 Q3 | 24 | 14 | 69 | 443 | 49 | 68 | 0.71 | 31.64 | 29.55 | |
109 | EBR - European Biopharmaceutical Review | journal | 6 | 105 | 0 | 454 | 0 | 0 | 0.00 | 4.32 | 29.82 | ||
108 | Environmental Pollutants and Bioavailability | journal | 39 | 18 | 36 | 454 | 30 | 35 | 0.30 | 25.22 | 38.98 | ||
107 | Journal of Liposome Research | journal | 0.394 Q2 | 64 | 14 | 87 | 459 | 95 | 81 | 1.37 | 32.79 | 44.23 | |
106 | Mathematical Medicine and Biology | journal | 0.473 Q2 | 49 | 17 | 50 | 468 | 50 | 49 | 0.94 | 27.53 | 13.95 | |
105 | Journal of Asian Natural Products Research | journal | 0.248 Q2 | 51 | 46 | 142 | 485 | 86 | 142 | 0.67 | 10.54 | 30.51 | |
104 | Pharmaceutical Statistics | journal | 46 | 32 | 0 | 508 | 0 | 0 | 0.00 | 15.88 | 32.61 | ||
103 | Toxicology and Industrial Health | journal | 0.304 Q3 | 69 | 18 | 99 | 534 | 64 | 97 | 0.44 | 29.67 | 33.78 | |
102 | Journal of Generic Medicines (discontinued) | journal | 0.224 Q2 | 16 | 43 | 11 | 543 | 5 | 10 | 0.45 | 12.63 | 34.21 | |
101 | Pharmaceutical Medicine | journal | 0.148 Q4 | 25 | 27 | 114 | 574 | 17 | 79 | 0.13 | 21.26 | 27.08 | |
100 | Human Genomics | journal | 2.980 Q1 | 68 | 36 | 7 | 587 | 11 | 7 | 1.57 | 16.31 | 33.33 | |
99 | DARU, Journal of Pharmaceutical Sciences | journal | 0.115 Q4 | 58 | 32 | 84 | 693 | 11 | 83 | 0.11 | 21.66 | 22.64 | |
98 | Cutaneous and Ocular Toxicology | journal | 0.127 Q4 | 37 | 27 | 71 | 740 | 9 | 68 | 0.18 | 27.41 | 39.56 | |
97 | Hospital Pharmacist | journal | 13 | 102 | 259 | 759 | 51 | 201 | 0.25 | 7.44 | 53.76 | ||
96 | Reviews in Contemporary Pharmacotherapy | journal | 0.557 Q2 | 18 | 1 | 11 | 854 | 16 | 11 | 1.40 | 854.00 | 0.00 | |
95 | Receptors and Channels | journal | 1.369 Q1 | 44 | 19 | 92 | 868 | 279 | 85 | 3.28 | 45.68 | 34.33 | |
94 | International Journal of Pharmacy Practice | journal | 0.349 Q2 | 44 | 34 | 107 | 924 | 67 | 105 | 0.64 | 27.18 | 63.75 | |
93 | International Journal of Cosmetic Science | journal | 0.217 Q2 | 77 | 28 | 113 | 958 | 77 | 110 | 0.70 | 34.21 | 30.16 | |
92 | Journal of Food Biochemistry | journal | 0.470 Q2 | 64 | 33 | 101 | 982 | 80 | 101 | 0.71 | 29.76 | 44.55 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®